References
- Balandrin MF, Kinghorn AD, Farnsworth NR (1993): Plant-derived natural products in drug discovery and develop-ment. An overview. In: Kinghorn AD, Balandrin MF, eds., Human Medicinal Agents from Plants, American Chemical Society Symposium Series 534. Washington, DC, American Chemical Society, pp. 2–12.
- Cragg GM (1998): Paclitaxel (Taxol): a success story with valu-able lessons for natural product drug discovery and devel-opment. Med Res Rev 18: 315–331.
- Cragg GM, Newman DJ (1999): Discovery and development of antineoplastic agents from natural sources. Cancer Invest 17: 153-163. da Rocha AB, Lopes RM, Schwartsmann G (2001): Natural pro-ducts in anticancer therapy. Curr Opin Pharmacol 1:364–369.
- Farnsworth NR (1994): Ethriopharmacology and drug devlop-ment. In: Chadwick DJ, Marsh J, eds., Ethnobotany and the Search for New Drugs, Chichester, UK, Wiley.
- Grabley S, Thiericke R (1999): Bioactive agents and natural sources: trends in discovery and application. Adv Biochem Eng Biotechnol 64: 101–154.
- Harvey AL (1999): Medicines from nature: are natural products still relevant to drug discovery? Trends Pharmacol Sci 20: 196–198.
- Mans DRA, da Rocha AB, Schwartsmann G (2000): Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 5: 185–198.
- Mans DRA, Jung FA, Schwartsmann G (1994): Anticancer drug discovery and development. Ciência e Cultura 46: 70–81.
- Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA (1997): The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des 12: 533–541.
- Sausville EA, Feigal E (1999): Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA. Ann Oncol 10: 1287–1291.
- Sausville EA, Johnson II (2000): Molecules for the millennium: how will they look? New drug discovery year 2000. Br J Cancer 83: 1401–1404.
- Schultes RE (1994): Amazonian ethnobotany and the search for new drugs. In: Chadwick DJ, Marsh J, eds., Ethnobotany and the Search for New Drugs, Ciba Foundation Sympo-sium 185. Chichester, Wiley, pp. 106–115.
- Schwartsmann G (2000): Marine organisms and other novel natural sources of new cancer drugs. Ann Oncol 11: 235–243.
- Shoemaker RH, Monks A, Alley MC, Scudiero DA, Fine DL, McLemore TL, Abbott BJ, Paull KD, Mayo JG, Boyd MR (1988): Development of human tumor cell line panels for use in disease-oriented drug screening. Prog Clin Biol Res 276: 265–286.
- Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990): New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107–1112.
- Workman P (2001): Scoring a bulls-eye against cancer genome targets. Curr Opin Pharmacol 1: 342–352.